Clinical Trial Results
Recent clinical trials showed highly reliable performanceView Clinical Data
*Acetaminophen dosages up to 1000 mg every four hours. Data on file.
Percent of sensors worn for the full 14 days.
Number of therapeutic substances tested, including ascorbic acid and acetaminophen, that did not affect the ability to use CGM readings.*
Percent of users evaluated who did not have an adverse reaction to the sensor adhesive.
AgaMatrix Holdings Announces Corporate Name Change and New CEO Rick Valencia, and Bayer Commercial Partnership in ChinaRead Article
WaveForm Technologies, Inc Awarded CE Mark Approval for Their CGM SystemRead Article
WaveForm Technologies and A. Menarini Diagnostics S.r.l. Enter Commercial Agreement for International Distribution of CGM SolutionsRead Article
Interested in learning more about WaveForm Diabetes?
Get in touch to learn about our products, company, and more.Contact Us